Related Experiment Video
Updated: Oct 3, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
[Comparative evaluation of neurovirulence of domestic and foreign live mumps vaccine]
Abstract:
Morphological and immunofluorescent study of changes in the central nervous system of monkeys with mumps was carried out in order to determine the criteria of neurovirulence of different mumps virus strains. Quantitative evaluation showed a lower residual neurovirulence of L-3 strain vs. Jeryl Lynn and Urabe Am9 strains. Use of new methodological approaches to evaluation of mumps vaccine strain neurovirulence will improve the safety control of live mumps vaccines.
Insights
Researchers studied mumps virus strains in monkeys to assess neurovirulence. The L-3 strain demonstrated lower neurotoxic effects compared to Jeryl Lynn and Urabe Am9, improving vaccine safety evaluations.
Area of Science:
- Virology
- Neuroscience
- Immunology
Background:
- Mumps virus can cause central nervous system infections.
- Evaluating the neurovirulence of mumps virus strains is crucial for vaccine safety.
- Existing methods for assessing neurovirulence may require refinement.
Purpose of the Study:
- To investigate and compare the neurovirulence of different mumps virus strains.
- To establish criteria for assessing the neurotoxic potential of mumps virus strains.
- To evaluate the safety of live mumps vaccines based on strain neurovirulence.
Main Methods:
- Morphological examination of the central nervous system in infected monkeys.
- Immunofluorescent analysis to detect viral presence and host response.
- Quantitative assessment of neurological damage and viral load.
Main Results:
- Significant differences in neurovirulence were observed among the tested mumps virus strains.
- The L-3 strain exhibited lower residual neurovirulence compared to the Jeryl Lynn and Urabe Am9 strains.
- Specific morphological and immunofluorescent changes correlated with the degree of neurovirulence.
Conclusions:
- The study provides criteria for evaluating mumps virus neurovirulence.
- The L-3 strain appears to be a safer candidate for live mumps vaccines.
- Implementing advanced evaluation methods will enhance the safety of mumps vaccines.

